Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Strategic Projects - Group

University of Toronto

$126,000.00

Oxygen therapeutics: Designs and tests

EF 2007-08

Résumé
Oxygen therapeutics are designed to enhance the availability of oxygen to a patient with a need such as in blood loss or disease. Such products have many valuable applications, including the ability to serve as a sterile, long-term alternative to a conventional transfusion, especially where blood banks are not easily reached. A common route to an oxygen therapeutic is based on chemically altering hemoglobin, to give a hemglobin-based oxygen carrier (HBOC). Work with HBOCs shows that they may cause elevated blood pressure. One likely reason is that interaction with nitric oxide, which is responsible for keeping blood vessels relaxed. Another possibility is a response to a sudden increase in oxygen from the HBOC. The research will produce characteristic modifications in hemoglobin to give defined HBOC molecules. Each will be used to test interaction with nitric oxide and oxygen release. We will test the effects in an animal model designed to determine vasoactivity. In a further aspect, we will prepare HBOC materials that are capable of adding nitric oxide, potentially reducing blood pressure. Designs will be iteratively improved with this information. At each stage we will discuss our progress with user sector participants.
Programme
Strategic Projects - Group
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
321928-2005
Name nom
Kluger, Ronald
Department département
Chemistry
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2005
Award amount
126000
Program id
STPGP
Program name en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1001
Committee name en
Strategic Projects Selection Panel - Biosciences A
Committee name fr
Comité de sélection des projets stratégiques - biosciences A
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
3
Nb partie
3
Application title
Oxygen therapeutics: Designs and tests
Keyword
NA
Application summary
Oxygen therapeutics are designed to enhance the availability of oxygen to a patient with a need such as in blood loss or disease. Such products have many valuable applications, including the ability to serve as a sterile, long-term alternative to a conventional transfusion, especially where blood banks are not easily reached. A common route to an oxygen therapeutic is based on chemically altering hemoglobin, to give a hemglobin-based oxygen carrier (HBOC). Work with HBOCs shows that they may cause elevated blood pressure. One likely reason is that interaction with nitric oxide, which is responsible for keeping blood vessels relaxed. Another possibility is a response to a sudden increase in oxygen from the HBOC. The research will produce characteristic modifications in hemoglobin to give defined HBOC molecules. Each will be used to test interaction with nitric oxide and oxygen release. We will test the effects in an animal model designed to determine vasoactivity. In a further aspect, we will prepare HBOC materials that are capable of adding nitric oxide, potentially reducing blood pressure. Designs will be iteratively improved with this information. At each stage we will discuss our progress with user sector participants.